Article contents
Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms
Published online by Cambridge University Press: 06 April 2020
Abstract
We characterized the impact of removal of the ESBL designation from microbiology reports on inpatient antibiotic prescribing. Definitive prescribing of carbapenems decreased from 48.4% to 16.1% (P = .01) and β-lactam–β-lactamase inhibitor combination increased from 19.4% to 61.3% (P = .002). Our findings confirm the importance of collaboration between microbiology and antimicrobial stewardship programs.
- Type
- Concise Communication
- Information
- Copyright
- © 2020 by The Society for Healthcare Epidemiology of America. All rights reserved
Footnotes
Present affiliations: Texas Children’s Hospital/Baylor College of Medicine, Houston, Texas [D.S.S.W] and Summa Health, Akron City Hospital, Akron, Ohio [M.E.])
PREVIOUS PRESENTATION: Some of these data were previously presented as a poster at the ASM Microbe 2018 conference on June 8, 2018, in Atlanta, Georgia.
References
- 3
- Cited by